FDA authorizes marketing of device to boost tongue muscles and reduce sleep apnea

The FDA announced today that it authorized the marketing of a device for reducing snoring and mild obstructive sleep apnea.

The prescription-only device is used while awake to improve tongue muscle function, which can help prevent the tongue from collapsing backward and obstructing the airway during sleep. It is the first device of this kind used while awake, according to a news release.

Signifier Medical Technologies‘ ExciteOSA device delivers electrical muscle stimulation through a mouthpiece sitting around the tongue. The mouthpiece consists of four electrodes, two above and below the tongue, each. The device’s sessions consist of a series of electrical pulses with rest periods in between, as it is used for 20 minutes once per day during a wakeful state over a six-week period. Then, it is used once per week thereafter.

The FDA observed the ExciteOSA device in 115 patients with snoring, including 48 with snoring and mild sleep apnea. All pa…

Read more
  • 0